ARA-290
Also known as: Cibinetide
ARA-290 (Cibinetide) is a synthetic 11-amino-acid peptide derived from the helix-B surface of erythropoietin (EPO), developed by Araim Pharmaceuticals. It selectively activates the innate repair receptor (IRR) for anti-inflammatory, tissue-protective, and neuroprotective signaling without stimulating erythropoiesis. ARA-290 is not FDA-approved; it has received FDA Fast Track and Orphan Drug designations for sarcoidosis-associated small fiber neuropathy and remains in clinical development as of April 2026.
0 listings, ranked by trust score
Each row is a (vendor, peptide) pair. Click through for the listing detail, the vendor's full trust profile, and any COAs they've published.
No vendors carrying this peptide are indexed yet.
COAs for ARA-290
18 third-party tests across 8 vendors. Each card links to the full report.
For
ARA-290
by Verified Peptides· batch ARA04260312C
For
ARA-290
by Peptide Supply Co.· batch AR1022026
For
ARA-290
by BioLongevity Labs· batch 2-3-46035
For
ARA-290
by BioLongevity Labs· batch cmojb6w60016nkirxxcy5khmm
For
ARA290
by Mile High Compounds· batch ARA-012-MH-01
For
ARA-290
by Skye Peptides· batch ARA25-16-004
For
ARA-290
by Profound Aminos· batch cmojb843w01gpkirxqc44yi4i
For
ARA-290
by Verified Peptides· batch cmojb5loj00x0kirxueirm4wr
For
ARA-290
by Skye Peptides· batch ARA25-16-003
For
ARA-290
by Profound Aminos· batch 2025-04-03
For
ARA-290
by Verified Peptides· batch 01-25-0112A
For
ARA-290
by Peptide Tech· batch cmpac5e260003tmrxbc4tckd2
For
ARA-290
by BioLongevity Labs· batch cmojb7cp501akkirxbr8ea2wa
For
ARA-290
by Glacier Aminos· batch ARA16GA01
Purity not on file
For
ARA-290
by Skye Peptides· batch ARA25-16-004
Purity not on file
For
ARA-290
by Skye Peptides· batch ARA25-16-004
Purity not on file
For
ARA-290
by Skye Peptides· batch ARA25-16-003
Purity not on file
For
ARA-290
by Skye Peptides· batch ARA25-16-003